Advanced BioMedical Technologies, Inc. (ABMT)

ABMT Income Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016
Revenue	0.11	0.12	0.01	-	-	-
Revenue Growth (YoY)	50.66%	960.20%	-	-	-	-
Cost of Revenue	0.03	0.05	0.01	-	-	-
Gross Profit	0.08	0.07	0	-	-	-
Selling, General & Admin	0.19	0.22	0.32	0.56	0.34	0.37
Research & Development	0.22	0.18	0.26	0.06	0.05	0.06
Operating Expenses	0.51	0.52	0.61	0.63	0.4	0.46
Operating Income	-0.42	-0.45	-0.6	-0.63	-0.4	-0.46
Interest Expense	-0.31	-0.33	-0.33	-0.3	-0.26	-0.25
Interest & Investment Income	0	0	0	0	0	0
Other Non Operating Income (Expenses)	-0.01	0.1	-0.02	-0.02	-0.03	-0.01
Pretax Income	-0.75	-0.67	-0.95	-0.95	-0.69	-0.72
Net Income	-0.75	-0.67	-0.95	-0.95	-0.69	-0.72
Net Income to Common	-0.75	-0.67	-0.95	-0.95	-0.69	-0.72
Shares Outstanding (Basic)	70	70	70	69	68	67
Shares Outstanding (Diluted)	70	70	70	69	68	67
Shares Change (YoY)	0.45%	0.69%	0.35%	1.62%	2.38%	17.26%
EPS (Basic)	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Free Cash Flow	-0.04	0.62	-0.76	-0.9	-0.56	-0.37
Free Cash Flow Per Share	-0.00	0.01	-0.01	-0.01	-0.01	-0.01
Gross Margin	74.32%	58.07%	34.84%	-	-	-
Operating Margin	-385.79%	-361.38%	-5187.77%	-	-	-
Profit Margin	-685.68%	-543.75%	-8139.49%	-	-	-
Free Cash Flow Margin	-39.45%	498.40%	-6529.08%	-	-	-
EBITDA	-0.41	-0.43	-0.58	-0.62	-0.39	-0.43
D&A For EBITDA	0.01	0.02	0.02	0.02	0.01	0.03
EBIT	-0.42	-0.45	-0.6	-0.63	-0.4	-0.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.